The Experts below are selected from a list of 936 Experts worldwide ranked by ideXlab platform
Nucci M. - One of the best experts on this subject based on the ideXlab platform.
-
Brazilian Guidelines For The Management Of Candidiasis - A Joint Meeting Report Of Three Medical Societies: Sociedade Brasileira De Infectologia, Sociedade Paulista De Infectologia And Sociedade Brasileira De Medicina Tropical
2015Co-Authors: Colombo A.l., Guimaraes T., Camargo L.f.a., Richtmann R., De Queiroz-telles F., Salles M.j.c., Da Cunha C.a., Yasuda M.a.s., Moretti M.l., Nucci M.Abstract:Candida infections account for 80% of all fungal infections in the hospital environment, including bloodstream, urinary tract and surgical site infections. Bloodstream infections are now a major challenge for tertiary hospitals worldwide due to their high prevalence and mortality rates. The incidence of candidemia in tertiary public hospitals in Brazil is approximately 2.5 cases per 1000 hospital admissions. Due to the importance of this infection, the authors provide a review of the diversity of the genus Candida and its clinical relevance, the therapeutic options and discuss the treatment of major infections caused by Candida. Each topography is discussed with regard to epidemiological, clinical and laboratory diagnostic and therapeutic recommendations based on levels of evidence. © 2013 Elsevier Editora Ltda.173283312Colombo, A.L., Guimarães, T., Epidemiology of hematogenous infections due to Candida spp. (2003) Rev Soc Bras Med Trop, 36, pp. 599-607Dignani, M.C., Solomkin, J.S., Anaissie, E., Candida (2003) Medical mycology. 1, pp. 195-239. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)Vanden Abbeele, A., de Meel, H., Ahariz, M., Perraudin, J.P., Beyer, I., Courtois, P., Denture contamination by yeasts in the elderly (2008) Gerodontology, 25, pp. 222-228Johnson, N.W., The mouth in HIV/AIDS: markers of disease status and management challenges for the dental profession (2010) Aust Dent J, 55 (SUPPL. 1), pp. 85-102Kennedy, M.A., Sobel, J.D., Vulvovaginal Candidiasis caused by non-albicans Candida species: new insights (2010) Curr Infect Dis Rep, 12, pp. 465-470Achkar, J.M., Fries, B.C., Candida infections of the genitourinary tract (2010) Clin Microbiol Rev, 23, pp. 253-273Morace, G., Borghi, E., Fungal infections in ICU patients: epidemiology and the role of diagnostics (2010) Minerva Anestesiol, 76, pp. 950-956Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia: the attributable mortality and excess length of stay (1988) Ann Intern Med, 148, pp. 2642-2645Colombo, A.L., Nucci, M., Park, B.J., Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers (2006) J Clin Microbiol, 44, pp. 2816-2823Bassetti, M., Trecarichi, E.M., Righi, E., Incidence, risk factors and predictors of outcome of candidemia: survey in 2 Italian university hospitals (2007) Diagn Microbiol Infect Dis, 58, pp. 325-331Diekema, D.J., Messer, S.A., Brueggemann, A.B., Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study (2002) J Clin Microbiol, 40, pp. 1298-1302Thom, K., Forrest, G., Gastrointestinal infections in immunocompromised hosts (2006) Curr Opin Gastroenterol, 22, pp. 18-23Pappas, P.G., Kauffman, C.A., Andes, D., Clinical practice guidelines for the management of Candidiasis: 2009 update by the Infectious Diseases Society of America (2009) Clin Infect Dis, 48, pp. 503-535Barbaro, G., Barbarini, G., Di Lorenzo, G., Fluconazole compared with itraconazole in the treatment of esophageal Candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study (1995) Scand J Infect Dis, 27, pp. 613-617Queiroz-Telles, F., Silva, N., Carvalho, M.M., Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal Candidiasis in AIDS patients (2001) Braz J Infect Dis, 5, pp. 60-66Ally, R., Schurmann, D., Kreisel, W., A randomized, double blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal Candidiasis in immunocompromised patients (2001) Clin Infect Dis, 33, pp. 1447-1454Vasquez, J.A., Skiest, D.J., Nieto, L., A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal Candidiasis in subjects with HIV/AIDS (2006) Clin Infect Dis, 42, pp. 1179-1186Skiest, D.J., Vazquez, J.A., Anstead, G.M., Posaconazole for the treatment of azole refractory oropharyngeal and esophageal Candidiasis in subjects with HIV infections (2007) Clin Infect Dis, 44, pp. 607-614Finlay, P.M., Richardson, M.D., Robertson, A.G., A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours (1996) Br J Oral Maxillofac Surg, 34, pp. 23-25Villanueva, A., Gotuzzo, E., Arathoon, E.G., A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal Candidiasis (2002) Am J Med, 113, pp. 294-299Krause, D.S., Simjee, A.E., van Rensburg, C., A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal Candidiasis (2004) Clin Infect Dis, 39, pp. 770-775Colombo, A.L., Guimarães, T., Candiduria: a clinical and therapeutic approach (2007) Rev Soc Bras Med Trop, 40, pp. 332-337deWet, N., Llanos-Cuentas, A., Suleiman, J., A randomized, double blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal Candidiasis in HIV positive patients (2004) Clin Infect Dis, 39, pp. 842-849Giraldo, P., Witkin, S., Vaginal Candidiasis: an incomprehensible challenge (1998) I Bras Dis Sex Transm, 10, pp. 31-36Holanda, A., Fernandes, A., Bezerra, C., Milan, E., Candidíase vulvovaginal: uma revisão de literatura (2005) Femina, 33, pp. 47-51Novawack, D., Lara, F., Estudo dos aspectos clínicos, epidemiológicos e atualização terapêutica das vulvovaginites por Candida sp, Trichomonas vaginalis e vaginoses bacterianas por Gardnerella vaginalis (1999) JBM, 77, pp. 46-50Galle, L., Gianinni, M., Prevalência e susceptibilidade de leveduras vaginais (2004) J Bras Patol Med Lab, 40, pp. 229-236Sobel, J.D., Pathogenesis and treatment of recurrent vulvovaginal Candidiasis (1992) Clin Infect Dis, 14, pp. S148-S153Sobel, J.D., Vulvovaginal candidosis (2007) Lancet, 369, pp. 1961-1971Costa, M., Fernandes, O., Silva, M., Candidíase vulvovaginal: aspectos clínicos, tratamento oral com azólicos e suscetibilidade in vitro (2003) Rev Pat Trop, 32, pp. 145-162Watson, M.C., Grimshaw, J.M., Bond, C.M., Mollison, J., Ludbrook, A., Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal Candidiasis (thrush): a systematic review (2002) BJOG, 109, pp. 85-95Urunsak, M., Ilkit, M., Euruke, C., Urunsak, I., Clinical and mycological efficacy of single-day oral treatment with itraconazole (400mg) in acute vulvovaginal candidosis (2004) Mycoses, 47, pp. 422-427Bennett, R.J., A Candida-based view of fungal sex and pathogenesis (2009) Genome Biol, 10, p. 230Kimberly, A.W., Stuart, M.B., Sexually transmitted diseases treatment guidelines 2006 (2006) MMWR, 55, pp. 1-54Sobel, J.D., Wiesenfeld, H.C., Martens, M., Maintenance fluconazole therapy for recurrent vulvovaginal Candidiasis (2004) N Engl J Med, 351, pp. 876-883Fong, I.W., The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal Candidiasis (1992) Genitourin Med, 68, pp. 374-377Witt, A., Kaufmann, U., Bitschnau, M., Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal Candidiasis: a randomised trial (2009) BJOG, 116, pp. 1499-1505Ray, D., Goswami, R., Banerjee, U., Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal Candidiasis (2007) Diabetes Care, 30, pp. 312-317Alvarez-Lerma, F., Nolla-Salas, J., Leon, C., Candiduria in critically ill patients admitted to intensive care medical units (2003) Intensive Care Med, 29, pp. 1069-1076Kauffman, C.A., Candiduria (2005) Clin Infect Dis, 41, pp. S371-S376Sobel, J.D., Fisher, J.F., Kauffman, C.A., Newman, C.A., Candida urinary tract infections - epidemiology (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S433-S436Nucci, M., Candiduria in hospitalized patients: a review (2000) Braz J Infect Dis, 4, pp. 168-172Oliveira, R.D., Maffei, C.M., Martinez, R., Nosocomial urinary tract infections by Candida species (2001) Rev Assoc Med Bras, 47, pp. 231-235Coleman, D.C., Rinaldi, M.G., Haynes, K.A., Importance of Candida species other than Candida albicans as opportunistic pathogens (1998) Med Mycol, 36 (SUPPL. 1), pp. 156-165Kobayashi, C.C., De Fernandes, O.F., Miranda, K.C., De Sousa, E.D., Silva Mdo, R., Candiduria in hospital patients: a study prospective (2004) Mycopathologia, 158, pp. 49-52Passos, X.S., Sales, W.S., Maciel, P.J., Candida colonization in intensive care unit patients' urine (2005) Mem Inst Oswaldo Cruz, 100, pp. 925-928Sobel, J.D., Controversies in the diagnosis of candiduria: what is the critical colony count (2002) Curr Treat Opt Infect Dis, 4, pp. 81-83Fisher, J.F., Newman, C.L., Sobel, J.D., Yeasts in the urine: solutions for a budding problem (1995) Clin Infect Dis, 20, pp. 183-189Ang, B.S.P., Telenti, A., King, B., Steckalberg, J.M., Wilson, W.D., Candidemia from urinary tract source: microbiological aspects and clinical significance (1993) Clin Infect Dis, 17, pp. 622-627Lundstrom, T., Sobel, J., Nosocomial candiduria: a review (2001) Clin Infect Dis, 32, pp. 1602-1607Sobel, J.D., Kauffman, C.A., McKinsey, D., Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo (2000) Clin Infect Dis, 30, pp. 19-24Fan-Havard, P., O'Donovan, C., Smith, S.M., Oh, J., Bamberger, M., Eng, R.H.K., Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria (1995) Clin Infect Dis, 21, pp. 960-965Fisher, J.F., Sobel, J.D., Kauffman, C.A., Newman, C.A., Candida urinary tract infections - treatment (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S457-S466Johnson, J.R., Should all catheterized patients with candiduria be treated? (1993) Clin Infect Dis, 17, p. 814Tavanti, A., Davidson, A.D., Gow, N.A., Maiden, M.C., Odds, F.C., Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III (2005) J Clin Microbiol, 43, pp. 284-292Bibashi, E., Memmos, D., Kokolina, E., Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases (2003) Clin Infect Dis, 36, pp. 927-931Powe, N.R., Septicemia in dialysis patients: incidence, risk factors and prognosis (1999) Kidney Int, 55, pp. 1081-1090Chen, K.H., Chang, C.T., Yu, C.C., Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis patients (2006) Ren Fail, 28, pp. 241-246Wang, A.Y., Yu, A.W., Li, P.K., Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center (2000) Am J Kidney Dis, 36, pp. 1183-1192Prasad, N., Gupta, A., Fungal peritonitis in peritoneal dialysis patients (2005) Perit Dial Int, 25, pp. 207-222Matuszkiewicz-Rowinska, J., Update on fungal peritonitis and its treatment (2009) Perit Dial Int, 29 (SUPPL. 2), pp. S161-S165Kameoka, H., Kumakawa, K., Matuoka, T., Nakano, M., Shiraiwa, Y., Yamaguchi, O., Intraperitoneal fluconazole for fungal peritonitis in CAPD: report of two cases (1999) Perit Dial Int, 19, pp. 481-483Wong, P.N., Lo, K.Y., Tong, G.M., Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine and delayed catheter replacement in continuous ambulatory peritoneal dialysis (2008) Perit Dial Int, 28, pp. 155-162Cornely, O.A., Lasso, M., Betts, R., Caspofungin for the treatment of less common forms of invasive Candidiasis (2007) J Antimicrob Chemother, 60, pp. 363-369Sandven, P., Qvist, H., Skovlund, E., Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations (2002) Crit Care Med, 30, pp. 541-547Gonçalves, S.S., Amorim, C.S., Nucci, M., Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil (2010) Clin Microbiol Infect, 16, pp. 885-887Calandra, T., Bille, J., Schneider, R., Mosimann, F., Francioli, P., Clinical significance of Candida isolated from peritoneum in surgical patients (1989) Lancet, 2, pp. 1437-1440Montravers, P., Dupont, H., Gauzit, R., Candida as a risk factor for mortality in peritonitis (2006) Crit Care Med, 34, pp. 646-652Solomkin, J.S., Mazuski, J.E., Bradley, J.S., Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America (2010) Clin Infect Dis, 50, pp. 133-164Stijn, I., Blota, B., Koenraad, H., Vandewoudea, B., Jan, J., Candida peritonitis (2007) Curr Opin Crit Care, 13, pp. 195-199Azoulay, E., Cohen, Y., Zahar, J.R., Practices in nonneutropenic ICU patients with Candida-positive airway specimens (2004) Intensive Care Med, 30, pp. 1384-1389Nunley, D.R., Gal, A.A., Vega, J.D., Perlino, C., Smith, P., Lawrence, E.C., Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation (2002) Chest, 122, pp. 1185-1191El-Ebiary, M., Torres, A., Fabregas, N., Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study (1997) Am J Respir Crit Care Med, 156, p. 583Alvarez-Lerma, F., Palomar, M., Leon, C., Fungal colonization and/or infection in intensive care units. Multicenter study of 1,562 patients (2003) Med Clin (Barc), 121, pp. 161-166Kontoyiannis, D.P., Reddy, B.T., Torres, H.A., Pulmonary Candidiasis in patients with cancer: an autopsy study (2002) Clin Infect Dis, 34, pp. 400-403Franquet, T., Muller, N.L., Lee, K.S., Oikonomou, A., Flint, J.D., Pulmonary Candidiasis after hematopoietic stem cell transplantation: thin-section CT findings (2005) Radiology, 236, pp. 332-337Hiller, E., Zavrel, M., Hauser, N., Adaptation, adhesion and invasion during interaction of Candida albicans with the host-focus on the function of cell wall proteins (2011) Int J Med Microbiol, 301, pp. 384-389Oner-Eyuboglu, F., Karacan, O., Akcay, S., Arslan, H., Demirhan, B., Haberal, M., Invasive Pulmonary fungal infections in solid organ transplant recipients: a four-year review (2003) Transplant Proc, 35, pp. 2689-2691Yamada, H., Kotaki, H., Takahashi, T., Recommendations for the treatment of fungal pneumonias (2003) Expert Opin Pharmacother, 4, pp. 1241-1258Cole, G.T., Halawa, A.A., Anaisse, E.J., The role of the gastrointestinal tract in hematogenous Candidiasis: from the laboratory to the bedside (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. 73-88Alexander, J.W., Boyce, S.T., Babcock, G.F., The process of microbial translocation (1990) Ann Surg, 212, pp. 496-510Lunel, F.M.V., Meis, J.F.G.M., Voss, A., Nosocomial fungal infections: candidemia (1999) Diagn Microbiol Infect Dis, 34, pp. 213-220Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia. The attributable mortality and excess length of stay (1988) Arch Intern Med, 148, pp. 2642-2645Colombo, A.L., Perfect, J., DiNubile, M., Global distribution and outcomes for Candida species causing invasive Candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive Candidiasis (2003) Eur J Clin Microbiol Infect Dis, 22, pp. 470-474Pasqualotto, A.C., Zimerman, R.A., Alves, S.H., Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil (2008) Infect Control Hosp Epidemiol, 29, pp. 898-899Debusk, C.H., Daoud, R., Thirumoorthi, M.C., Wilson, F.M., Khatib, R., Candidemia: current epidemiologic characteristics and a long term follow-up of the survivors (1994) Scand J Infect Dis, 26, pp. 697-703Kriengkauykiat, J., Ito, J.I., Dadwal, S.S., Epidemiology and treatment approaches in management of invasive fungal infections (2011) Clin Epidemiol, 3, pp. 175-191Ben-Ami, R., Garcia-Effron, G., Lewis, R.E., Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance (2011) J Infect Dis, 204, pp. 626-635Bodey, G.P., Luna, M., Skin lesions associated with disseminated Candidiasis (1974) JAMA, 229, pp. 1466-1468Rodriguez-Adrian, L.J., King, R.T., Tamayo-Derat, L.G., Miller, J.W., Garcia, C.A., Rex, J.H., Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology (2003) Medicine (Baltimore), 82, pp. 187-202Oude Lashof, A.M., Rothova, A., Sobel, J.D., Ocular manifestations of candidemia (2011) Clin Infect Dis, 53, pp. 262-268Krishna, R., Amuh, D., Lowder, C.Y., Gordon, S.M., Adal, K.A., Hall, G., Should all patients with candidemia have an ophthalmic examination to rule out ocular Candidiasis (2000) Eye, 14, pp. 30-34Filler, S.G., Kullberg, B.J., Deep-seated candidal infections (2003) Medical mycology, pp. 341-348. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)Donnino, M.W., Goyal, N., Terlecki, T.M., Inadequate blood volume collected for culture: a survey of health care professionals (2007) Mayo Clin Proc, 82, pp. 1069-1072Horvath, L.L., George, B.J., Hospenthal, D.R., Detection of fifteen species of Candida in an automated blood culture system (2007) J Clin Microbiol, 45, pp. 3062-3064Masood, A., Sallah, S., Chronic disseminated Candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment (2005) Leuk Res, 29, pp. 493-501Almirante, B., Cuenca-Estrella, M., Candidemia: impact of epidemiological studies on the treatment and prognosis of a serious infection (2011) Enferm Infecc Microbiol Clin, 29, pp. 325-327Motta, A.L., Almeida, G.M., Almeida Júnior, J.N., Burattini, M.N., Rossi, F., Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex (2010) Braz J Infect Dis, 14, pp. 441-448Sanglard, D., Odds, F.C., Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences (2002) Lancet Infect Dis, 2, pp. 73-85Andes, D.R., Safdar, N., Baddley, J.W., (2012), 54, pp. 1110-1122. , for the Mycoses Study Group. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive Candidiasis: a patient-level quantitative review of randomized trials. Clin Infect DisRex, J.H., Pappas, P.G., Karchmer, A.W., A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects (2003) Clin Infect Dis, 36, pp. 1221-1228Bates, D.W., Su, L., Yu, D.T., Mortality and costs of acute renal failure assSullivan, D., Coleman, D., Candida dubliniensis: characteristics and identification (1998) J Clin Microbiol, 36, pp. 329-334Mariano, P.L., Milan, E.P., da Matta, D.A., Colombo, A.L., Candida dubliniensis identification in Brazilian yeast stock collection (2003) Mem Inst Oswaldo Cruz, 98, pp. 533-538Krcmery, V., Barnes, A.J., Non-albicans Candida spp. causing fungemia: pathogenicity and antifungal resistance (2002) J Hosp Infect, 50, pp. 243-260Godoy, P., Tiraboschi, I.N., Severo, L.C., Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals (2003) Mem Inst Oswaldo Cruz, 98, pp. 401-405Pfaller, M.A., Nosocomial Candidiasis: emerging species, reservoirs and modes of transmission (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. S89-S94Colombo, A.L., Guimarães, T., Silva, L.R., Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality (2007) Infect Control Hosp Epidemiol, 28, pp. 570-576Costa, S.F., Marinho, I., Araújo, E.A., Manrique, A.E., Medeiros, E.A.S., Levin, A.S., Nosocomial fungaemia: a 2-year prospective study (2000) J Hosp Infect, 45, pp. 69-72Levin, A.S., Costa, S.F., Mussi, N.S., Candida parapsilosis fungemia associated with implantable and semiimplantable central venous catheters and the hands of health care workers (1998) Diagn Microbiol Infect Dis, 30, pp. 243-249Pfaller, M.A., Messer, S.A., Moet, G.J., Jones, R.N., Castanheira, M., Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENT RY Antimicrobial Surveillance Program (2008-2009) (2011) Int J Antimicrob Agents, 38, pp. 65-69Pfaller, M.A., Diekema, D.J., Ostrosky-Zeichner, L., Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints (2008) J Clin Microbiol, 46, pp. 2620-2629Mora-Duarte, J., Betts, R., Rotstein, C., Comparison of caspofungin and amphotericin B for invasive Candidiasis (2002) N Engl J Med, 347, pp. 2020-2029Kuse, E.R., Chetchotisakd, P., da Cunha, C.A., Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial (2007) Lancet, 369, pp. 1519-1527Reboli, A.C., Rotstein, C., Pappas, P.G., Anidulafungin versus fluconazole for invasive Candidiasis (2007) N Engl J Med, 356, pp. 2472-2482Kofteridis, D.P., Lewis, R.E., Kontoyiannis, D.P., Caspofungin-nonsusceptible Candida isolates in cancer patients (2010) J Antimicrob Chemother, 65, pp. 293-295Colombo, A.L., Ngai, A.L., Bourque, M., Caspofungin use in patients with invasive Candidiasis caused by common non-albicans Candida species: review of the caspofungin database (2010) Antimicrob Agents Chemother, 54, pp. 1864-1871Kale-Pradhan, P.B., Morgan, G., Wilhelm, S.M., Johnson, L.B., Comparativ
-
Brazilian Guidelines For The Management Of Candidiasis: A Joint Meeting Report Of Three Medical Societies - Sociedade Brasileira De Infectologia, Sociedade Paulista De Infectologia, Sociedade Brasileira De Medicina Tropical
2015Co-Authors: Lopes Colombo A., Guimaraes T., Richtmann R., Da Cunha C.a., Aranha Camargo L.f., Queiroz-telles F.d., Costa Salles M.j., Shikanai Yasuda, Luiza Moretti M., Nucci M.Abstract:[No abstract available]16SUPPL. 1S1S34Colombo, A.L., Guimarães, T., Epidemiology of hematogenous infections due to Candida spp (2003) Rev Soc Bras Med Trop, 36 (5), pp. 599-607Dignani, M.C., Solomkin, J.S., Anaissie, E., Candida (2003) Medical Mycology, pp. 195-239. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)Vanden Abbeele, A., de Meel, H., Ahariz, M., Perraudin, J.P., Beyer, I., Courtois, P., Denture contamination by yeasts in the elderly (2008) Gerodontology, 25 (4), pp. 222-228Johnson, N.W., The mouth in HIV/AIDS: markers of disease status and management challenges for the dental profession (2010) Aust Dent J, 55 (SUPPL. 1), pp. 85-102Kennedy, M.A., Sobel, J.D., Vulvovaginal Candidiasis caused by non-albicans Candida species: new insights (2010) Curr Infect Dis Rep, 12 (6), pp. 465-470Achkar, J.M., Fries, B.C., Candida infections of the genitourinary tract (2010) Clin Microbiol Rev, 23 (2), pp. 253-273Morace, G., Borghi, E., Fungal infections in ICU patients: epidemiology and the role of diagnostics (2010) Minerva Anestesiol, 76 (11), pp. 950-956Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia: the attributable mortality and excess length of stay (1988) Arch Internal Med, 148, pp. 2642-2645Colombo, A.L., Nucci, M., Park, B.J., Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers (2006) J Clin Microbiol, 44 (8), pp. 2816-2823Bassetti, M., Trecarichi, E.M., Righi, E., Incidence, risk factors and predictors of outcome of candidemia: survey in 2 Italian university hospitals (2007) Diagn Microbiol Infect Dis, 58 (3), pp. 325-331Diekema, D.J., Messer, S.A., Brueggemann, A.B., Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study (2002) J Clin Microbiol, 40 (4), pp. 1298-1302Cha, R., Sobel, J.D., Fluconazole for the treatment of Candidiasis: 15 years experience (2004) Expert Rev Anti Infect Ther, 2 (3), pp. 357-366Thom, K., Forrest, G., Gastrointestinal infections in immunocompromised hosts (2006) Curr Opin Gastroenterol, 22 (1), pp. 18-23Pappas, P.G., Kauffman, C.A., Andes, D., Infectious Diseases Society of America Clinical practice guidelines for the management of Candidiasis: 2009 update by the Infectious Diseases Society of America (2009) Clin Infect Dis, 48 (5), pp. 503-535Barbaro, G., Barbarini, G., Di Lorenzo, G., Fluconazole compared with itraconazole in the treatment of esophageal Candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study (1995) Scand J Infect Dis, 27 (6), pp. 613-617Queiroz-Telles, F., Silva, N., Carvalho, M.M., Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal Candidiasis in Aids patients (2001) Braz J Infect Dis, 5, pp. 60-66Ally, R., Schurmann, D., Kreisel, W., A randomized, doubleblind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal Candidiasis in immunocompromised patients (2001) Clin Infect Dis, 33, pp. 1447-1454Vasquez, J.A., Skiest, D.J., Nieto, L., A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal Candidiasis in subjects with HIV/AIDS (2006) Clin Infect Dis, 42, pp. 1179-1186Skiest, D.J., Vazquez, J.A., Anstead, G.M., Posaconazole for the treatment of azole refractory oropharyngeal and esophageal Candidiasis in subjects with HIV infections (2007) Clin Infect Dis, 44, pp. 607-614Finlay, P.M., Richardson, M.D., Robertson, A.G., A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours (1996) Br J Oral Maxillofac Surg, 34, pp. 23-25Villanueva, A., Gotuzzo, E., Arathoon, E.G., A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal Candidiasis (2002) Am J Med, 113 (4), pp. 294-299Colombo, A.L., Guimarães, T., Candiduria: a clinical and therapeutic approach (2007) Rev Soc Bras Med Trop, 40 (3), pp. 332-337Krause, D.S., Simjee, A.E., van Rensburg, C., A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal Candidiasis (2004) Clin Infect Dis, 39 (6), pp. 770-775deWet, N., Llanos-Cuentas, A., Suleiman, J., A randomized, doubleblind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal Candidiasis in HIVpositive patients (2004) Clin Infect Dis, 39, pp. 842-849Giraldo, P., Witkin, S., Vaginal Candidiasis: an incompreehensible challenge (1998) I Bras Dis Sex Transm, 10 (5), pp. 31-36Holanda, A., Fernandes, A., Bezerra, C., Milan, E., Candidíase vulvovaginal: uma revisão de literatura (2005) Femina, 33 (5), pp. 347-351Novawack, D., Lara, F., Estudo dos aspectos clínicos, epidemiológicos e atualização terapêutica das vulvovaginites por Candida sp, Trichomonas vaginalis e vaginoses bacterianas por Gardnerella vaginalis (1999) JBM, 77, pp. 46-50Galle, L., Gianinni, M., Prevalência e susceptibilidade de leveduras vaginais (2004) J Bras Patol Med Lab, 40 (4), pp. 229-236Sobel, J.D., Pathogenesis and treatment of recurrent vulvovaginal Candidiasis (1992) Clin Infect Dis, 14, pp. S148-S153Sobel, J.D., Vulvovaginal candidosis (2007) Lancet, 369, pp. 1961-1971Costa, M., Fernandes, O., Silva, M., Candidíase vulvovaginal: aspectos clínicos, tratamento oral com azólicos e suscetibilidade in vitro (2003) Revista de Patologia Tropical, 32 (2), pp. 145-162Watson, M.C., Grimshaw, J.M., Bond, C.M., Mollison, J., Ludbrook, A., Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal Candidiasis (thrush): a systematic review (2002) Bjog, 109, pp. 85-95Bennett, R.J., A Candida-based view of fungal sex and pathogenesis (2009) Genome Biol, 10 (7), p. 230Urunsak, M., Ilkit, M., Euruke, C., Urunsak, I., Clinical and mycological efficacy of single-day oral treatment with itraconazole (400mg) in acute vulvovaginal candidosis (2004) Mycoses, 47, pp. 422-427Kimberly, A.W., Stuart, M.B., Sexually transmitted diseases treatment guidelines 2006 (2006) MMWR, 55, pp. 1-54Sobel, J.D., Wiesenfeld, H.C., Martens, M., Maintenance fluconazole therapy for recurrent vulvovaginal Candidiasis (2004) N Engl J Med, 351, pp. 876-883Fong, I.W., The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal Candidiasis (1992) Genitourin Med, 68 (6), pp. 374-377Witt, A., Kaufmann, U., Bitschnau, M., Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal Candidiasis: a randomised trial (2009) BJOG, 116 (11), pp. 1499-1505Ray, D., Goswami, R., Banerjee, U., Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal Candidiasis (2007) Diabetes Care, 30 (2), pp. 312-317Alvarez-Lerma, F., Nolla-Salas, J., Leon, C., Candiduria in critically ill patients admitted to intensive care medical units (2003) Intensive Care Medicine, 29, pp. 1069-1076Kauffman, C.A., Candiduria (2005) Clin Infect Dis, 41, pp. S371-S376Sobel, J.D., Fisher, J.F., Kauffman, C.A., Newman, C.A., Candida urinary tract infections-epidemiology (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S433-S436Nucci, M., Candiduria in hospitalized patients: a review (2000) Braz J Infect Dis, 4, pp. 168-172Coleman, D.C., Rinaldi, M.G., Haynes, K.A., Importance of Candida species other than Candida albicans as opportunistic pathogens (1998) Med Mycol, 36 (SUPPL. 1), pp. 156-165Oliveira, R.D., Maffei, C.M., Martinez, R., Nosocomial urinary tract infections by Candida species (2001) Rev Assoc Med Bras, 47 (3), pp. 231-235Kobayashi, C.C., De Fernandes, O.F., Miranda, K.C., De Sousa, E.D., Silva Mdo, R., Candiduria in hospital patients: a study prospective (2004) Mycopathologia, 158, pp. 49-52Passos, X.S., Sales, W.S., Maciel, P.J., Candida colonization in intensive care unit patients' urine (2005) Memórias do Instituto Oswaldo Cruz, 100, pp. 925-928Colombo, A.L., Guimarães, T., Candiduria: a clinical and therapeutic approach (2007) Rev Soc Bras Med Trop, 40 (3), pp. 332-337Sobel, J.D., Controversies in the diagnosis of candiduria: what is the critical colony count (2002) Curr Treat Options Infect Dis, 4, pp. 81-83Fisher, J.F., Newman, C.L., Sobel, J.D., Yeasts in the urine: solutions for a budding problem (1995) Clin Infect Dis, 20, pp. 183-189Ang, B.S.P., Telenti, A., King, B., Steckalberg, J.M., Wilson, W.D., Candidemia from urinary tract source: microbiological aspects and clinical significance (1993) Clin Infect Dis, 17, pp. 622-627Lundstrom, T., Sobel, J., Nosocomial candiduria: a review (2001) Clin Infect Dis, 32, pp. 1602-1607Sobel, J.D., Kauffman, C.A., McKinsey, D., Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo (2000) Clin Infect Dis, 30, pp. 19-24Fan-Havard, P., O'Donovan, C., Smith, S.M., Oh, J., Bamberger, M., Eng, R.H.K., Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria (1995) Clin Infect Dis, 21, pp. 960-965Tavanti, A., Davidson, A.D., Gow, N.A., Maiden, M.C., Odds, F.C., Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III (2005) J Clin Microbiol, 43 (1), pp. 284-292Fisher, J.F., Sobel, J.D., Kauffman, C.A., Newman, C.A., Candida urinary tract infections-treatment (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S457-S466Johnson, J.R., Should all catheterized patients with candiduria be treated? (1993) Clin Infect Dis, 17, p. 814Bibashi, E., Memmos, D., Kokolina, E., Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases (2003) Clin Infec Dis, 36, pp. 927-931Powe, N.R., Septicemia in dialysis patients: incidence, risk factors and prognosis (1999) Kidney International, 55, pp. 1081-1090Chen, K.H., Chang, C.T., Yu, C.C., Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis patients (2006) Renal Failure, 28 (3), pp. 241-246Wang, A.Y., Yu, A.W., Li, P.K., Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center (2000) Am J Kidney Dis, 36 (6), pp. 1183-1192Prasad, N., Gupta, A., Fungal peritonitis in peritoneal dialysis patients (2005) Perit Dial Int, 25 (3), pp. 207-222Matuszkiewicz-Rowinska, J., Update on fungal peritonitis and its treatment (2009) Perit Dial Int, 29 (SUPPL. 2), pp. S161-S165Kameoka, H., Kumakawa, K., Matuoka, T., Nakano, M., Shiraiwa, Y., Yamaguchi, O., Intraperitoneal fluconazole for fungal peritonitis in CAPD: report of two cases (1999) Perit Dial Int, 19 (5), pp. 481-483Wong, P.N., Lo, K.Y., Tong, G.M., Chan, S.F., Lo, M.W., Mak, S.K., Wong, A.K., Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine and delayed catheter replacement in continuous ambulatory peritoneal dialysis (2008) Perit Dial Int, 28 (2), pp. 155-162Gonçalves, S.S., Amorim, C.S., Nucci, M., Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil (2010) Clin Microbiol Infect, 16 (7), pp. 885-887Cornely, O.A., Lasso, M., Betts, R., Caspofungin for the treatment of less common forms of invasive Candidiasis (2007) J Antimicrob Chemother, 60 (2), pp. 363-369Sandven, P., Qvist, H., Skovlund, E., Giercksky, K.E., Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations (2002) Crit Care Med, 30 (3), pp. 541-547. , NO RGAS Group and the Norwegian Yeast Study GroupCalandra, T., Bille, J., Schneider, R., Mosimann, F., Francioli, P., Clinical significance of Candida isolated from peritoneum in surgical patients (1989) Lancet, 2 (8677), pp. 1437-1440Montravers, P., Dupont, H., Gauzit, R., Candida as a risk factor for mortality in peritonitis (2006) Crit Care Med, 34 (3), pp. 646-652Solomkin, J.S., Mazuski, J.E., Bradley, J.S., Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America (2010) Clin Infect Dis, 50 (2), pp. 133-164Stijn, I., Blota, B., Koenraad, H., Vandewoudea, B., Jan, J., Candida peritonitis (2007) Curr Opinion Crit Care, 13, pp. 195-199Azoulay, E., Cohen, Y., Zahar, J.R., Practices in nonneutropenic ICU patients with Candida-positive airway specimens (2004) Intensive Care Med, 30 (7), pp. 1384-1389Nunley, D.R., Gal, A.A., Vega, J.D., Perlino, C., Smith, P., Lawrence, E.C., Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation (2002) Chest, 122, pp. 1185-1191El-Ebiary, M., Torres, A., Fabregas, N., Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients An immediate postmortem histologic study (1997) Am J Respir Crit Care Med, 156, p. 583Alvarez-Lerma, F., Palomar, M., Leon, C., Olaechea, P., Cerda, E., Bermejo, B., Grupo de Estudio de Infecion Fungica Fungal colonization and/or infection in intensive care units. Multicenter study of 1,562 patients (2003) Med Clin (Barc), 121 (5), pp. 161-166Hiller, E., Zavrel, M., Hauser, N., Adaptation, adhesion and invasion during interaction of Candida albicans with the host-focus on the function of cell wall proteins (2011) Int J Med Microbiol, 301 (5), pp. 384-389Kontoyiannis, D.P., Reddy, B.T., Torres, H.A., Pulmonary Candidiasis in patients with cancer: an autopsy study (2002) Clin Infect Dis, 34, pp. 400-403Franquet, T., Muller, N.L., Lee, K.S., Oikonomou, A., Flint, J.D., Pulmonary Candidiasis after hematopoietic stem cell transplantation: thin-section CT findings (2005) Radiology, 236, pp. 332-337Oner-Eyuboglu, F., Karacan, O., Akcay, S., Arslan, H., Demirhan, B., Haberal, M., Invasive Pulmonary fungal infections in solid organ transplant recipients: a four-year review (2003) Transplant Proc, 35 (7), pp. 2689-2691Yamada, H., Kotaki, H., Takahashi, T., Recommendations for the treatment of fungal pneumonias (2003) Expert Opin Pharmacother, 4 (8), pp. 1241-1258Cole, G.T., Halawa, A.A., Anaisse, E.J., The role of the gastrointestinal tract in hematogenous Candidiasis: from the laboratory to the bedside (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. 73-88Alexander, J.W., Boyce, S.T., Babcock, G.F., The process of microbial translocation (1990) Annals of Surgery, 212, pp. 496-510Pfaller, M.A., Nosocomial Candidiasis: emerging species, reservoirs and modes of transmission (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. S89-S94Lunel, F.M.V., Meis, J.F.G.M., Voss, A., Nosocomial fungal infections: candidemia (1999) Diagn Microbiol Infect Dis, 34, pp. 213-220Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia The attributable mortality and excess length of stay (1988) Arch Int Med, 148, pp. 2642-2645Colombo, A.L., Perfect, J., DiNubile, M., Global distribution and outcomes for Candida species causing invasive Candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive Candidiasis (2003) Eur J Clin Microbiol Infect Dis, 22, pp. 470-474Ben-Ami, R., Garcia-Effron, G., Lewis, R.E., Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance (2011) J Infect Dis, 204 (4), pp. 626-635Pasqualotto, A.C., Zimerman, R.A., Alves, S.H., Aquino, V.R., Branco, D., Wiltgen, D., do Amaral, A., Sukiennik, T.C., Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil (2008) Infect Control Hosp Epidemiol, 29 (9), pp. 898-899Debusk, C.H., Daoud, R., Thirumoorthi, M.C., Wilson, F.M., Khatib, R., Candidemia: current epidemiologic characteristics and a longterm follow-up of the survivors (1994) Scand J Infect Dis, 26, pp. 697-703Kriengkauykiat, J., Ito, J.I., Dadwal, S.S., Epidemiology and treatment approaches in management of invasive fungal infections (2011) Clin Epidemiol, 3, pp. 175-191Bodey, G.P., Luna, M., Skin lesions associated with disseminated Candidiasis (1974) JAMA, 229, pp. 1466-1468Rodriguez-Adrian, L.J., King, R.T., Tamayo-Derat, L.G., Miller, J.W., Garcia, C.A., Rex, J.H., Retinal lesions as clues to disseminated bacterial and candidal infections: Frequency, natural history, and etiology (2003) Medicine (Baltimore), 82, pp. 187-202Oude Lashof, A.M., Rothova, A., Sobel, J.D., Ocular manifestations of candidemia (2011) Clin Infect Dis, 53 (3), pp. 262-268Krishna, R., Amuh, D., Lowder, C.Y., Gordon, S.M., Adal, K.A., Hall, G., Should all patients with candidemia have an ophthalmic examination to rule out ocular Candidiasis? (2000) Eye, 14, pp. 30-34Filler, S.G., Kullberg, B.J., Deep-seated candidal infections (2003) Medical Mycology, pp. 341-348. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)Donnino, M.W., Goyal, N., Terlecki, T.M., Inadequate blood volume collected for culture: a survey of health care professionals (2007) Mayo Clin Proc, 82 (9), pp. 1069-1072Horvath, L.L., George, B.J., Hospenthal, D.R., Detection of fifteen species of Candida in an automated blood cultSanglard, D., Odds, F.C., Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences (2002) Lancet Infect Dis, 2, pp. 73-85Sullivan, D., Coleman, D., Candida dubliniensis: characteristics and identification (1998) J Clin Microbiol, 36, pp. 329-334Mariano, P.L., Milan, E.P., da Matta, D.A., Colombo, A.L., Candida dubliniensis identification in Brazilian yeast stock collection (2003) Mem Inst Oswaldo Cruz, 98 (4), pp. 533-538Krcmery, V., Barnes, A.J., Non-albicans Candida spp. causing fungemia: pathogenicity and antifungal resistance (2002) J Hosp Infect, 50, pp. 243-260Godoy, P., Tiraboschi, I.N., Severo, L.C., Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals (2003) Mem Instit Oswaldo Cruz, 98, pp. 401-405Pfaller, M.A., Nosocomial Candidiasis: emerging species, reservoirs and modes of transmission (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. S89-S94Colombo, A.L., Guimarães, T., Silva, L.R., Prospective observational study of candidemia in São Paulo Brazil: incidence rate, epidemiology, and predictors of mortality (2007) Infect Control Hosp Epidemiol, 28 (5), pp. 570-576Costa, S.F., Marinho, I., Araújo, E.A., Manrique, A.E., Medeiros, E.A.S., Levin, A.S., Nosocomial fungaemia: a 2-year prospective study (2000) J Hosp Infect, 45, pp. 69-72Levin, A.S., Costa, S.F., Mussi, N.S., Candida parapsilosis fungemia associated with implantable and semiimplantable central venous catheters and the hands of health care workers (1998) Diagn Microbiol Infect Dis, 30, pp. 243-249Pfaller, M.A., Messer, S.A., Moet, G.J., Jones, R.N., Castanheira, M., Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENT RY Antimicrobial Surveillance Program (2008-2009) (2011) Int J Antimicrob Agents, 38 (1), pp. 65-69Pfaller, M.A., Diekema, D.J., Ostrosky-Zeichner, L., Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints (2008) J Clin Microbiol, 46 (8), pp. 2620-2629Mora-Duarte, J., Betts, R., Rotstein, C., Comparison of caspofungin and amphotericin B for invasive Candidiasis (2002) N Engl J Med, 347 (25), pp. 2020-2029Kuse, E.R., Chetchotisakd, P., da Cunha, C.A., Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial (2007) Lancet, 369 (9572), pp. 1519-1527Reboli, A.C., Rotstein, C., Pappas, P.G., Anidulafungin versus fluconazole for invasive Candidiasis (2007) N Engl J Med, 356 (24), pp. 2472-2482Kofteridis, D.P., Lewis, R.E., Kontoyiannis, D.P., Caspofungin-nonsusceptible Candida isolates in cancer patients (2010) J Antimicrob Chemother, 65 (2), pp. 293-295Colombo, A.L., Ngai, A.L., Bourque, M., Caspofungin use in patients with invasive Candidiasis caused by common non-albicans Candida species: review of the caspofungin database (2010) Antimicrob Agents Chemother, 54 (5), pp. 1864-1871Kale-Pradhan, P.B., Morgan, G., Wilhelm, S.M., Johnson, L.B., Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis Infections: a meta-analysis (2010) Pharmacotherapy, 30 (12), pp. 1207-1213Melo, A.S., Bizerra, F.C., Freymüller, E., Arthington-Skaggs, B.A., Colombo, A.L., Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex (2011) Med Mycol, 49 (3), pp. 253-262Wingard, J.R., Importance of Candida species other than C. albicans as pathogens in oncology patients (1995) Clin Infect Dis, 20, pp. 115-125Colombo, A.L., Nucci, M., Salomão, R., High rate of nonalbicans candidemia in Brazilian tertiary care hospitals (1999) Diagn Microbiol Infect Dis, 34, pp. 281-286Goldani, L.Z., Mario, P.S., Candida tropicalis fungemia in a tertiary care hospital (2003) J Infect, 46, pp. 150-160Alp, S., Sancak, B., Hascelik, G., Arikan, S., Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing
Anil K. Jaiswal - One of the best experts on this subject based on the ideXlab platform.
-
Phospholipid changes in guinea pig lungs in Pulmonary Candidiasis.
Toxicon, 2002Co-Authors: Anil K. JaiswalAbstract:Abstract Phospholipid changes were studied in guinea pig lungs at 30, 90 and 150 days after intratracheal inoculation of Candida albicans organisms. At 30 days the individual phospholipids were unaffected, while at 90 and 150 days, phosphatidylcholine, phosphatidylethanolamine, lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidic acid and sphingomyelin showed significant decreases, and phosphatidylserine and phosphatidylinositol did not change.
I Raad - One of the best experts on this subject based on the ideXlab platform.
-
Pulmonary Candidiasis in patients with cancer an autopsy study
Clinical Infectious Diseases, 2002Co-Authors: Dimitrios P Kontoyiannis, Bhavananda T Reddy, Harrys A Torres, Mario A Luna, Russell E Lewis, Jeffrey J Tarrand, Gerald P Bodey, I RaadAbstract:For patients who had cancer and autopsy-proven pneumonia, we evaluated whether cultures of respiratory secretions (sputum and/or bronchoalveolar lavage) performed < or =4 weeks before autopsy were a reliable basis for the diagnosis of Pulmonary Candidiasis. Pulmonary Candidiasis was identified at autopsy in 36 patients, but common clinical predictors were insensitive for this diagnosis. For sputum culture, the sensitivity, specificity, and the positive and negative predictive values were 85%, 60%, 42%, and 93%, respectively; for bronchoalveolar lavage culture, these values were 71%, 57%, 29%, and 89%, respectively.
Julia Flint - One of the best experts on this subject based on the ideXlab platform.
-
Pulmonary Candidiasis after hematopoietic stem cell transplantation thin section ct findings
Radiology, 2005Co-Authors: Tomas Franquet, Nestor L Muller, Kyung Soo Lee, Anastasia Oikonomou, Julia FlintAbstract:PURPOSE: To retrospectively evaluate thin-section computed tomographic (CT) findings in hematopoietic stem cell transplant (ie, bone marrow transplant) patients with histopathologically proved Pulmonary Candidiasis. MATERIALS AND METHODS: Ethical approval was obtained from the institutional review board of each of the three institutions; informed consent was not required. The study included 17 hematopoietic stem cell transplant recipients with proved Pulmonary Candidiasis. Histopathologic specimens were acquired at transbronchial biopsy (n = 8), open lung biopsy (n = 6), and autopsy (n = 3). The patients included seven men and 10 women (age range, 20–62 years; mean age, 37 years). The thin-section CT scans were retrospectively reviewed by two thoracic radiologists for the presence, appearance, and distribution of parenchymal abnormalities. RESULTS: Multiple nodules were present in 15 (88%) patients, including centrilobular nodules and tree-in-bud pattern in seven (41%) patients. Nodules were bilateral in ...
Guimaraes T. - One of the best experts on this subject based on the ideXlab platform.
-
Brazilian Guidelines For The Management Of Candidiasis - A Joint Meeting Report Of Three Medical Societies: Sociedade Brasileira De Infectologia, Sociedade Paulista De Infectologia And Sociedade Brasileira De Medicina Tropical
2015Co-Authors: Colombo A.l., Guimaraes T., Camargo L.f.a., Richtmann R., De Queiroz-telles F., Salles M.j.c., Da Cunha C.a., Yasuda M.a.s., Moretti M.l., Nucci M.Abstract:Candida infections account for 80% of all fungal infections in the hospital environment, including bloodstream, urinary tract and surgical site infections. Bloodstream infections are now a major challenge for tertiary hospitals worldwide due to their high prevalence and mortality rates. The incidence of candidemia in tertiary public hospitals in Brazil is approximately 2.5 cases per 1000 hospital admissions. Due to the importance of this infection, the authors provide a review of the diversity of the genus Candida and its clinical relevance, the therapeutic options and discuss the treatment of major infections caused by Candida. Each topography is discussed with regard to epidemiological, clinical and laboratory diagnostic and therapeutic recommendations based on levels of evidence. © 2013 Elsevier Editora Ltda.173283312Colombo, A.L., Guimarães, T., Epidemiology of hematogenous infections due to Candida spp. (2003) Rev Soc Bras Med Trop, 36, pp. 599-607Dignani, M.C., Solomkin, J.S., Anaissie, E., Candida (2003) Medical mycology. 1, pp. 195-239. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)Vanden Abbeele, A., de Meel, H., Ahariz, M., Perraudin, J.P., Beyer, I., Courtois, P., Denture contamination by yeasts in the elderly (2008) Gerodontology, 25, pp. 222-228Johnson, N.W., The mouth in HIV/AIDS: markers of disease status and management challenges for the dental profession (2010) Aust Dent J, 55 (SUPPL. 1), pp. 85-102Kennedy, M.A., Sobel, J.D., Vulvovaginal Candidiasis caused by non-albicans Candida species: new insights (2010) Curr Infect Dis Rep, 12, pp. 465-470Achkar, J.M., Fries, B.C., Candida infections of the genitourinary tract (2010) Clin Microbiol Rev, 23, pp. 253-273Morace, G., Borghi, E., Fungal infections in ICU patients: epidemiology and the role of diagnostics (2010) Minerva Anestesiol, 76, pp. 950-956Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia: the attributable mortality and excess length of stay (1988) Ann Intern Med, 148, pp. 2642-2645Colombo, A.L., Nucci, M., Park, B.J., Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers (2006) J Clin Microbiol, 44, pp. 2816-2823Bassetti, M., Trecarichi, E.M., Righi, E., Incidence, risk factors and predictors of outcome of candidemia: survey in 2 Italian university hospitals (2007) Diagn Microbiol Infect Dis, 58, pp. 325-331Diekema, D.J., Messer, S.A., Brueggemann, A.B., Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study (2002) J Clin Microbiol, 40, pp. 1298-1302Thom, K., Forrest, G., Gastrointestinal infections in immunocompromised hosts (2006) Curr Opin Gastroenterol, 22, pp. 18-23Pappas, P.G., Kauffman, C.A., Andes, D., Clinical practice guidelines for the management of Candidiasis: 2009 update by the Infectious Diseases Society of America (2009) Clin Infect Dis, 48, pp. 503-535Barbaro, G., Barbarini, G., Di Lorenzo, G., Fluconazole compared with itraconazole in the treatment of esophageal Candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study (1995) Scand J Infect Dis, 27, pp. 613-617Queiroz-Telles, F., Silva, N., Carvalho, M.M., Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal Candidiasis in AIDS patients (2001) Braz J Infect Dis, 5, pp. 60-66Ally, R., Schurmann, D., Kreisel, W., A randomized, double blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal Candidiasis in immunocompromised patients (2001) Clin Infect Dis, 33, pp. 1447-1454Vasquez, J.A., Skiest, D.J., Nieto, L., A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal Candidiasis in subjects with HIV/AIDS (2006) Clin Infect Dis, 42, pp. 1179-1186Skiest, D.J., Vazquez, J.A., Anstead, G.M., Posaconazole for the treatment of azole refractory oropharyngeal and esophageal Candidiasis in subjects with HIV infections (2007) Clin Infect Dis, 44, pp. 607-614Finlay, P.M., Richardson, M.D., Robertson, A.G., A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours (1996) Br J Oral Maxillofac Surg, 34, pp. 23-25Villanueva, A., Gotuzzo, E., Arathoon, E.G., A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal Candidiasis (2002) Am J Med, 113, pp. 294-299Krause, D.S., Simjee, A.E., van Rensburg, C., A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal Candidiasis (2004) Clin Infect Dis, 39, pp. 770-775Colombo, A.L., Guimarães, T., Candiduria: a clinical and therapeutic approach (2007) Rev Soc Bras Med Trop, 40, pp. 332-337deWet, N., Llanos-Cuentas, A., Suleiman, J., A randomized, double blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal Candidiasis in HIV positive patients (2004) Clin Infect Dis, 39, pp. 842-849Giraldo, P., Witkin, S., Vaginal Candidiasis: an incomprehensible challenge (1998) I Bras Dis Sex Transm, 10, pp. 31-36Holanda, A., Fernandes, A., Bezerra, C., Milan, E., Candidíase vulvovaginal: uma revisão de literatura (2005) Femina, 33, pp. 47-51Novawack, D., Lara, F., Estudo dos aspectos clínicos, epidemiológicos e atualização terapêutica das vulvovaginites por Candida sp, Trichomonas vaginalis e vaginoses bacterianas por Gardnerella vaginalis (1999) JBM, 77, pp. 46-50Galle, L., Gianinni, M., Prevalência e susceptibilidade de leveduras vaginais (2004) J Bras Patol Med Lab, 40, pp. 229-236Sobel, J.D., Pathogenesis and treatment of recurrent vulvovaginal Candidiasis (1992) Clin Infect Dis, 14, pp. S148-S153Sobel, J.D., Vulvovaginal candidosis (2007) Lancet, 369, pp. 1961-1971Costa, M., Fernandes, O., Silva, M., Candidíase vulvovaginal: aspectos clínicos, tratamento oral com azólicos e suscetibilidade in vitro (2003) Rev Pat Trop, 32, pp. 145-162Watson, M.C., Grimshaw, J.M., Bond, C.M., Mollison, J., Ludbrook, A., Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal Candidiasis (thrush): a systematic review (2002) BJOG, 109, pp. 85-95Urunsak, M., Ilkit, M., Euruke, C., Urunsak, I., Clinical and mycological efficacy of single-day oral treatment with itraconazole (400mg) in acute vulvovaginal candidosis (2004) Mycoses, 47, pp. 422-427Bennett, R.J., A Candida-based view of fungal sex and pathogenesis (2009) Genome Biol, 10, p. 230Kimberly, A.W., Stuart, M.B., Sexually transmitted diseases treatment guidelines 2006 (2006) MMWR, 55, pp. 1-54Sobel, J.D., Wiesenfeld, H.C., Martens, M., Maintenance fluconazole therapy for recurrent vulvovaginal Candidiasis (2004) N Engl J Med, 351, pp. 876-883Fong, I.W., The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal Candidiasis (1992) Genitourin Med, 68, pp. 374-377Witt, A., Kaufmann, U., Bitschnau, M., Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal Candidiasis: a randomised trial (2009) BJOG, 116, pp. 1499-1505Ray, D., Goswami, R., Banerjee, U., Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal Candidiasis (2007) Diabetes Care, 30, pp. 312-317Alvarez-Lerma, F., Nolla-Salas, J., Leon, C., Candiduria in critically ill patients admitted to intensive care medical units (2003) Intensive Care Med, 29, pp. 1069-1076Kauffman, C.A., Candiduria (2005) Clin Infect Dis, 41, pp. S371-S376Sobel, J.D., Fisher, J.F., Kauffman, C.A., Newman, C.A., Candida urinary tract infections - epidemiology (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S433-S436Nucci, M., Candiduria in hospitalized patients: a review (2000) Braz J Infect Dis, 4, pp. 168-172Oliveira, R.D., Maffei, C.M., Martinez, R., Nosocomial urinary tract infections by Candida species (2001) Rev Assoc Med Bras, 47, pp. 231-235Coleman, D.C., Rinaldi, M.G., Haynes, K.A., Importance of Candida species other than Candida albicans as opportunistic pathogens (1998) Med Mycol, 36 (SUPPL. 1), pp. 156-165Kobayashi, C.C., De Fernandes, O.F., Miranda, K.C., De Sousa, E.D., Silva Mdo, R., Candiduria in hospital patients: a study prospective (2004) Mycopathologia, 158, pp. 49-52Passos, X.S., Sales, W.S., Maciel, P.J., Candida colonization in intensive care unit patients' urine (2005) Mem Inst Oswaldo Cruz, 100, pp. 925-928Sobel, J.D., Controversies in the diagnosis of candiduria: what is the critical colony count (2002) Curr Treat Opt Infect Dis, 4, pp. 81-83Fisher, J.F., Newman, C.L., Sobel, J.D., Yeasts in the urine: solutions for a budding problem (1995) Clin Infect Dis, 20, pp. 183-189Ang, B.S.P., Telenti, A., King, B., Steckalberg, J.M., Wilson, W.D., Candidemia from urinary tract source: microbiological aspects and clinical significance (1993) Clin Infect Dis, 17, pp. 622-627Lundstrom, T., Sobel, J., Nosocomial candiduria: a review (2001) Clin Infect Dis, 32, pp. 1602-1607Sobel, J.D., Kauffman, C.A., McKinsey, D., Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo (2000) Clin Infect Dis, 30, pp. 19-24Fan-Havard, P., O'Donovan, C., Smith, S.M., Oh, J., Bamberger, M., Eng, R.H.K., Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria (1995) Clin Infect Dis, 21, pp. 960-965Fisher, J.F., Sobel, J.D., Kauffman, C.A., Newman, C.A., Candida urinary tract infections - treatment (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S457-S466Johnson, J.R., Should all catheterized patients with candiduria be treated? (1993) Clin Infect Dis, 17, p. 814Tavanti, A., Davidson, A.D., Gow, N.A., Maiden, M.C., Odds, F.C., Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III (2005) J Clin Microbiol, 43, pp. 284-292Bibashi, E., Memmos, D., Kokolina, E., Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases (2003) Clin Infect Dis, 36, pp. 927-931Powe, N.R., Septicemia in dialysis patients: incidence, risk factors and prognosis (1999) Kidney Int, 55, pp. 1081-1090Chen, K.H., Chang, C.T., Yu, C.C., Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis patients (2006) Ren Fail, 28, pp. 241-246Wang, A.Y., Yu, A.W., Li, P.K., Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center (2000) Am J Kidney Dis, 36, pp. 1183-1192Prasad, N., Gupta, A., Fungal peritonitis in peritoneal dialysis patients (2005) Perit Dial Int, 25, pp. 207-222Matuszkiewicz-Rowinska, J., Update on fungal peritonitis and its treatment (2009) Perit Dial Int, 29 (SUPPL. 2), pp. S161-S165Kameoka, H., Kumakawa, K., Matuoka, T., Nakano, M., Shiraiwa, Y., Yamaguchi, O., Intraperitoneal fluconazole for fungal peritonitis in CAPD: report of two cases (1999) Perit Dial Int, 19, pp. 481-483Wong, P.N., Lo, K.Y., Tong, G.M., Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine and delayed catheter replacement in continuous ambulatory peritoneal dialysis (2008) Perit Dial Int, 28, pp. 155-162Cornely, O.A., Lasso, M., Betts, R., Caspofungin for the treatment of less common forms of invasive Candidiasis (2007) J Antimicrob Chemother, 60, pp. 363-369Sandven, P., Qvist, H., Skovlund, E., Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations (2002) Crit Care Med, 30, pp. 541-547Gonçalves, S.S., Amorim, C.S., Nucci, M., Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil (2010) Clin Microbiol Infect, 16, pp. 885-887Calandra, T., Bille, J., Schneider, R., Mosimann, F., Francioli, P., Clinical significance of Candida isolated from peritoneum in surgical patients (1989) Lancet, 2, pp. 1437-1440Montravers, P., Dupont, H., Gauzit, R., Candida as a risk factor for mortality in peritonitis (2006) Crit Care Med, 34, pp. 646-652Solomkin, J.S., Mazuski, J.E., Bradley, J.S., Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America (2010) Clin Infect Dis, 50, pp. 133-164Stijn, I., Blota, B., Koenraad, H., Vandewoudea, B., Jan, J., Candida peritonitis (2007) Curr Opin Crit Care, 13, pp. 195-199Azoulay, E., Cohen, Y., Zahar, J.R., Practices in nonneutropenic ICU patients with Candida-positive airway specimens (2004) Intensive Care Med, 30, pp. 1384-1389Nunley, D.R., Gal, A.A., Vega, J.D., Perlino, C., Smith, P., Lawrence, E.C., Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation (2002) Chest, 122, pp. 1185-1191El-Ebiary, M., Torres, A., Fabregas, N., Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study (1997) Am J Respir Crit Care Med, 156, p. 583Alvarez-Lerma, F., Palomar, M., Leon, C., Fungal colonization and/or infection in intensive care units. Multicenter study of 1,562 patients (2003) Med Clin (Barc), 121, pp. 161-166Kontoyiannis, D.P., Reddy, B.T., Torres, H.A., Pulmonary Candidiasis in patients with cancer: an autopsy study (2002) Clin Infect Dis, 34, pp. 400-403Franquet, T., Muller, N.L., Lee, K.S., Oikonomou, A., Flint, J.D., Pulmonary Candidiasis after hematopoietic stem cell transplantation: thin-section CT findings (2005) Radiology, 236, pp. 332-337Hiller, E., Zavrel, M., Hauser, N., Adaptation, adhesion and invasion during interaction of Candida albicans with the host-focus on the function of cell wall proteins (2011) Int J Med Microbiol, 301, pp. 384-389Oner-Eyuboglu, F., Karacan, O., Akcay, S., Arslan, H., Demirhan, B., Haberal, M., Invasive Pulmonary fungal infections in solid organ transplant recipients: a four-year review (2003) Transplant Proc, 35, pp. 2689-2691Yamada, H., Kotaki, H., Takahashi, T., Recommendations for the treatment of fungal pneumonias (2003) Expert Opin Pharmacother, 4, pp. 1241-1258Cole, G.T., Halawa, A.A., Anaisse, E.J., The role of the gastrointestinal tract in hematogenous Candidiasis: from the laboratory to the bedside (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. 73-88Alexander, J.W., Boyce, S.T., Babcock, G.F., The process of microbial translocation (1990) Ann Surg, 212, pp. 496-510Lunel, F.M.V., Meis, J.F.G.M., Voss, A., Nosocomial fungal infections: candidemia (1999) Diagn Microbiol Infect Dis, 34, pp. 213-220Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia. The attributable mortality and excess length of stay (1988) Arch Intern Med, 148, pp. 2642-2645Colombo, A.L., Perfect, J., DiNubile, M., Global distribution and outcomes for Candida species causing invasive Candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive Candidiasis (2003) Eur J Clin Microbiol Infect Dis, 22, pp. 470-474Pasqualotto, A.C., Zimerman, R.A., Alves, S.H., Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil (2008) Infect Control Hosp Epidemiol, 29, pp. 898-899Debusk, C.H., Daoud, R., Thirumoorthi, M.C., Wilson, F.M., Khatib, R., Candidemia: current epidemiologic characteristics and a long term follow-up of the survivors (1994) Scand J Infect Dis, 26, pp. 697-703Kriengkauykiat, J., Ito, J.I., Dadwal, S.S., Epidemiology and treatment approaches in management of invasive fungal infections (2011) Clin Epidemiol, 3, pp. 175-191Ben-Ami, R., Garcia-Effron, G., Lewis, R.E., Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance (2011) J Infect Dis, 204, pp. 626-635Bodey, G.P., Luna, M., Skin lesions associated with disseminated Candidiasis (1974) JAMA, 229, pp. 1466-1468Rodriguez-Adrian, L.J., King, R.T., Tamayo-Derat, L.G., Miller, J.W., Garcia, C.A., Rex, J.H., Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology (2003) Medicine (Baltimore), 82, pp. 187-202Oude Lashof, A.M., Rothova, A., Sobel, J.D., Ocular manifestations of candidemia (2011) Clin Infect Dis, 53, pp. 262-268Krishna, R., Amuh, D., Lowder, C.Y., Gordon, S.M., Adal, K.A., Hall, G., Should all patients with candidemia have an ophthalmic examination to rule out ocular Candidiasis (2000) Eye, 14, pp. 30-34Filler, S.G., Kullberg, B.J., Deep-seated candidal infections (2003) Medical mycology, pp. 341-348. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)Donnino, M.W., Goyal, N., Terlecki, T.M., Inadequate blood volume collected for culture: a survey of health care professionals (2007) Mayo Clin Proc, 82, pp. 1069-1072Horvath, L.L., George, B.J., Hospenthal, D.R., Detection of fifteen species of Candida in an automated blood culture system (2007) J Clin Microbiol, 45, pp. 3062-3064Masood, A., Sallah, S., Chronic disseminated Candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment (2005) Leuk Res, 29, pp. 493-501Almirante, B., Cuenca-Estrella, M., Candidemia: impact of epidemiological studies on the treatment and prognosis of a serious infection (2011) Enferm Infecc Microbiol Clin, 29, pp. 325-327Motta, A.L., Almeida, G.M., Almeida Júnior, J.N., Burattini, M.N., Rossi, F., Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex (2010) Braz J Infect Dis, 14, pp. 441-448Sanglard, D., Odds, F.C., Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences (2002) Lancet Infect Dis, 2, pp. 73-85Andes, D.R., Safdar, N., Baddley, J.W., (2012), 54, pp. 1110-1122. , for the Mycoses Study Group. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive Candidiasis: a patient-level quantitative review of randomized trials. Clin Infect DisRex, J.H., Pappas, P.G., Karchmer, A.W., A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects (2003) Clin Infect Dis, 36, pp. 1221-1228Bates, D.W., Su, L., Yu, D.T., Mortality and costs of acute renal failure assSullivan, D., Coleman, D., Candida dubliniensis: characteristics and identification (1998) J Clin Microbiol, 36, pp. 329-334Mariano, P.L., Milan, E.P., da Matta, D.A., Colombo, A.L., Candida dubliniensis identification in Brazilian yeast stock collection (2003) Mem Inst Oswaldo Cruz, 98, pp. 533-538Krcmery, V., Barnes, A.J., Non-albicans Candida spp. causing fungemia: pathogenicity and antifungal resistance (2002) J Hosp Infect, 50, pp. 243-260Godoy, P., Tiraboschi, I.N., Severo, L.C., Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals (2003) Mem Inst Oswaldo Cruz, 98, pp. 401-405Pfaller, M.A., Nosocomial Candidiasis: emerging species, reservoirs and modes of transmission (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. S89-S94Colombo, A.L., Guimarães, T., Silva, L.R., Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality (2007) Infect Control Hosp Epidemiol, 28, pp. 570-576Costa, S.F., Marinho, I., Araújo, E.A., Manrique, A.E., Medeiros, E.A.S., Levin, A.S., Nosocomial fungaemia: a 2-year prospective study (2000) J Hosp Infect, 45, pp. 69-72Levin, A.S., Costa, S.F., Mussi, N.S., Candida parapsilosis fungemia associated with implantable and semiimplantable central venous catheters and the hands of health care workers (1998) Diagn Microbiol Infect Dis, 30, pp. 243-249Pfaller, M.A., Messer, S.A., Moet, G.J., Jones, R.N., Castanheira, M., Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENT RY Antimicrobial Surveillance Program (2008-2009) (2011) Int J Antimicrob Agents, 38, pp. 65-69Pfaller, M.A., Diekema, D.J., Ostrosky-Zeichner, L., Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints (2008) J Clin Microbiol, 46, pp. 2620-2629Mora-Duarte, J., Betts, R., Rotstein, C., Comparison of caspofungin and amphotericin B for invasive Candidiasis (2002) N Engl J Med, 347, pp. 2020-2029Kuse, E.R., Chetchotisakd, P., da Cunha, C.A., Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial (2007) Lancet, 369, pp. 1519-1527Reboli, A.C., Rotstein, C., Pappas, P.G., Anidulafungin versus fluconazole for invasive Candidiasis (2007) N Engl J Med, 356, pp. 2472-2482Kofteridis, D.P., Lewis, R.E., Kontoyiannis, D.P., Caspofungin-nonsusceptible Candida isolates in cancer patients (2010) J Antimicrob Chemother, 65, pp. 293-295Colombo, A.L., Ngai, A.L., Bourque, M., Caspofungin use in patients with invasive Candidiasis caused by common non-albicans Candida species: review of the caspofungin database (2010) Antimicrob Agents Chemother, 54, pp. 1864-1871Kale-Pradhan, P.B., Morgan, G., Wilhelm, S.M., Johnson, L.B., Comparativ
-
Brazilian Guidelines For The Management Of Candidiasis: A Joint Meeting Report Of Three Medical Societies - Sociedade Brasileira De Infectologia, Sociedade Paulista De Infectologia, Sociedade Brasileira De Medicina Tropical
2015Co-Authors: Lopes Colombo A., Guimaraes T., Richtmann R., Da Cunha C.a., Aranha Camargo L.f., Queiroz-telles F.d., Costa Salles M.j., Shikanai Yasuda, Luiza Moretti M., Nucci M.Abstract:[No abstract available]16SUPPL. 1S1S34Colombo, A.L., Guimarães, T., Epidemiology of hematogenous infections due to Candida spp (2003) Rev Soc Bras Med Trop, 36 (5), pp. 599-607Dignani, M.C., Solomkin, J.S., Anaissie, E., Candida (2003) Medical Mycology, pp. 195-239. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)Vanden Abbeele, A., de Meel, H., Ahariz, M., Perraudin, J.P., Beyer, I., Courtois, P., Denture contamination by yeasts in the elderly (2008) Gerodontology, 25 (4), pp. 222-228Johnson, N.W., The mouth in HIV/AIDS: markers of disease status and management challenges for the dental profession (2010) Aust Dent J, 55 (SUPPL. 1), pp. 85-102Kennedy, M.A., Sobel, J.D., Vulvovaginal Candidiasis caused by non-albicans Candida species: new insights (2010) Curr Infect Dis Rep, 12 (6), pp. 465-470Achkar, J.M., Fries, B.C., Candida infections of the genitourinary tract (2010) Clin Microbiol Rev, 23 (2), pp. 253-273Morace, G., Borghi, E., Fungal infections in ICU patients: epidemiology and the role of diagnostics (2010) Minerva Anestesiol, 76 (11), pp. 950-956Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia: the attributable mortality and excess length of stay (1988) Arch Internal Med, 148, pp. 2642-2645Colombo, A.L., Nucci, M., Park, B.J., Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers (2006) J Clin Microbiol, 44 (8), pp. 2816-2823Bassetti, M., Trecarichi, E.M., Righi, E., Incidence, risk factors and predictors of outcome of candidemia: survey in 2 Italian university hospitals (2007) Diagn Microbiol Infect Dis, 58 (3), pp. 325-331Diekema, D.J., Messer, S.A., Brueggemann, A.B., Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study (2002) J Clin Microbiol, 40 (4), pp. 1298-1302Cha, R., Sobel, J.D., Fluconazole for the treatment of Candidiasis: 15 years experience (2004) Expert Rev Anti Infect Ther, 2 (3), pp. 357-366Thom, K., Forrest, G., Gastrointestinal infections in immunocompromised hosts (2006) Curr Opin Gastroenterol, 22 (1), pp. 18-23Pappas, P.G., Kauffman, C.A., Andes, D., Infectious Diseases Society of America Clinical practice guidelines for the management of Candidiasis: 2009 update by the Infectious Diseases Society of America (2009) Clin Infect Dis, 48 (5), pp. 503-535Barbaro, G., Barbarini, G., Di Lorenzo, G., Fluconazole compared with itraconazole in the treatment of esophageal Candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study (1995) Scand J Infect Dis, 27 (6), pp. 613-617Queiroz-Telles, F., Silva, N., Carvalho, M.M., Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal Candidiasis in Aids patients (2001) Braz J Infect Dis, 5, pp. 60-66Ally, R., Schurmann, D., Kreisel, W., A randomized, doubleblind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal Candidiasis in immunocompromised patients (2001) Clin Infect Dis, 33, pp. 1447-1454Vasquez, J.A., Skiest, D.J., Nieto, L., A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal Candidiasis in subjects with HIV/AIDS (2006) Clin Infect Dis, 42, pp. 1179-1186Skiest, D.J., Vazquez, J.A., Anstead, G.M., Posaconazole for the treatment of azole refractory oropharyngeal and esophageal Candidiasis in subjects with HIV infections (2007) Clin Infect Dis, 44, pp. 607-614Finlay, P.M., Richardson, M.D., Robertson, A.G., A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours (1996) Br J Oral Maxillofac Surg, 34, pp. 23-25Villanueva, A., Gotuzzo, E., Arathoon, E.G., A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal Candidiasis (2002) Am J Med, 113 (4), pp. 294-299Colombo, A.L., Guimarães, T., Candiduria: a clinical and therapeutic approach (2007) Rev Soc Bras Med Trop, 40 (3), pp. 332-337Krause, D.S., Simjee, A.E., van Rensburg, C., A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal Candidiasis (2004) Clin Infect Dis, 39 (6), pp. 770-775deWet, N., Llanos-Cuentas, A., Suleiman, J., A randomized, doubleblind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal Candidiasis in HIVpositive patients (2004) Clin Infect Dis, 39, pp. 842-849Giraldo, P., Witkin, S., Vaginal Candidiasis: an incompreehensible challenge (1998) I Bras Dis Sex Transm, 10 (5), pp. 31-36Holanda, A., Fernandes, A., Bezerra, C., Milan, E., Candidíase vulvovaginal: uma revisão de literatura (2005) Femina, 33 (5), pp. 347-351Novawack, D., Lara, F., Estudo dos aspectos clínicos, epidemiológicos e atualização terapêutica das vulvovaginites por Candida sp, Trichomonas vaginalis e vaginoses bacterianas por Gardnerella vaginalis (1999) JBM, 77, pp. 46-50Galle, L., Gianinni, M., Prevalência e susceptibilidade de leveduras vaginais (2004) J Bras Patol Med Lab, 40 (4), pp. 229-236Sobel, J.D., Pathogenesis and treatment of recurrent vulvovaginal Candidiasis (1992) Clin Infect Dis, 14, pp. S148-S153Sobel, J.D., Vulvovaginal candidosis (2007) Lancet, 369, pp. 1961-1971Costa, M., Fernandes, O., Silva, M., Candidíase vulvovaginal: aspectos clínicos, tratamento oral com azólicos e suscetibilidade in vitro (2003) Revista de Patologia Tropical, 32 (2), pp. 145-162Watson, M.C., Grimshaw, J.M., Bond, C.M., Mollison, J., Ludbrook, A., Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal Candidiasis (thrush): a systematic review (2002) Bjog, 109, pp. 85-95Bennett, R.J., A Candida-based view of fungal sex and pathogenesis (2009) Genome Biol, 10 (7), p. 230Urunsak, M., Ilkit, M., Euruke, C., Urunsak, I., Clinical and mycological efficacy of single-day oral treatment with itraconazole (400mg) in acute vulvovaginal candidosis (2004) Mycoses, 47, pp. 422-427Kimberly, A.W., Stuart, M.B., Sexually transmitted diseases treatment guidelines 2006 (2006) MMWR, 55, pp. 1-54Sobel, J.D., Wiesenfeld, H.C., Martens, M., Maintenance fluconazole therapy for recurrent vulvovaginal Candidiasis (2004) N Engl J Med, 351, pp. 876-883Fong, I.W., The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal Candidiasis (1992) Genitourin Med, 68 (6), pp. 374-377Witt, A., Kaufmann, U., Bitschnau, M., Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal Candidiasis: a randomised trial (2009) BJOG, 116 (11), pp. 1499-1505Ray, D., Goswami, R., Banerjee, U., Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal Candidiasis (2007) Diabetes Care, 30 (2), pp. 312-317Alvarez-Lerma, F., Nolla-Salas, J., Leon, C., Candiduria in critically ill patients admitted to intensive care medical units (2003) Intensive Care Medicine, 29, pp. 1069-1076Kauffman, C.A., Candiduria (2005) Clin Infect Dis, 41, pp. S371-S376Sobel, J.D., Fisher, J.F., Kauffman, C.A., Newman, C.A., Candida urinary tract infections-epidemiology (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S433-S436Nucci, M., Candiduria in hospitalized patients: a review (2000) Braz J Infect Dis, 4, pp. 168-172Coleman, D.C., Rinaldi, M.G., Haynes, K.A., Importance of Candida species other than Candida albicans as opportunistic pathogens (1998) Med Mycol, 36 (SUPPL. 1), pp. 156-165Oliveira, R.D., Maffei, C.M., Martinez, R., Nosocomial urinary tract infections by Candida species (2001) Rev Assoc Med Bras, 47 (3), pp. 231-235Kobayashi, C.C., De Fernandes, O.F., Miranda, K.C., De Sousa, E.D., Silva Mdo, R., Candiduria in hospital patients: a study prospective (2004) Mycopathologia, 158, pp. 49-52Passos, X.S., Sales, W.S., Maciel, P.J., Candida colonization in intensive care unit patients' urine (2005) Memórias do Instituto Oswaldo Cruz, 100, pp. 925-928Colombo, A.L., Guimarães, T., Candiduria: a clinical and therapeutic approach (2007) Rev Soc Bras Med Trop, 40 (3), pp. 332-337Sobel, J.D., Controversies in the diagnosis of candiduria: what is the critical colony count (2002) Curr Treat Options Infect Dis, 4, pp. 81-83Fisher, J.F., Newman, C.L., Sobel, J.D., Yeasts in the urine: solutions for a budding problem (1995) Clin Infect Dis, 20, pp. 183-189Ang, B.S.P., Telenti, A., King, B., Steckalberg, J.M., Wilson, W.D., Candidemia from urinary tract source: microbiological aspects and clinical significance (1993) Clin Infect Dis, 17, pp. 622-627Lundstrom, T., Sobel, J., Nosocomial candiduria: a review (2001) Clin Infect Dis, 32, pp. 1602-1607Sobel, J.D., Kauffman, C.A., McKinsey, D., Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo (2000) Clin Infect Dis, 30, pp. 19-24Fan-Havard, P., O'Donovan, C., Smith, S.M., Oh, J., Bamberger, M., Eng, R.H.K., Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria (1995) Clin Infect Dis, 21, pp. 960-965Tavanti, A., Davidson, A.D., Gow, N.A., Maiden, M.C., Odds, F.C., Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III (2005) J Clin Microbiol, 43 (1), pp. 284-292Fisher, J.F., Sobel, J.D., Kauffman, C.A., Newman, C.A., Candida urinary tract infections-treatment (2011) Clin Infect Dis, 52 (SUPPL. 6), pp. S457-S466Johnson, J.R., Should all catheterized patients with candiduria be treated? (1993) Clin Infect Dis, 17, p. 814Bibashi, E., Memmos, D., Kokolina, E., Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases (2003) Clin Infec Dis, 36, pp. 927-931Powe, N.R., Septicemia in dialysis patients: incidence, risk factors and prognosis (1999) Kidney International, 55, pp. 1081-1090Chen, K.H., Chang, C.T., Yu, C.C., Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis patients (2006) Renal Failure, 28 (3), pp. 241-246Wang, A.Y., Yu, A.W., Li, P.K., Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center (2000) Am J Kidney Dis, 36 (6), pp. 1183-1192Prasad, N., Gupta, A., Fungal peritonitis in peritoneal dialysis patients (2005) Perit Dial Int, 25 (3), pp. 207-222Matuszkiewicz-Rowinska, J., Update on fungal peritonitis and its treatment (2009) Perit Dial Int, 29 (SUPPL. 2), pp. S161-S165Kameoka, H., Kumakawa, K., Matuoka, T., Nakano, M., Shiraiwa, Y., Yamaguchi, O., Intraperitoneal fluconazole for fungal peritonitis in CAPD: report of two cases (1999) Perit Dial Int, 19 (5), pp. 481-483Wong, P.N., Lo, K.Y., Tong, G.M., Chan, S.F., Lo, M.W., Mak, S.K., Wong, A.K., Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine and delayed catheter replacement in continuous ambulatory peritoneal dialysis (2008) Perit Dial Int, 28 (2), pp. 155-162Gonçalves, S.S., Amorim, C.S., Nucci, M., Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil (2010) Clin Microbiol Infect, 16 (7), pp. 885-887Cornely, O.A., Lasso, M., Betts, R., Caspofungin for the treatment of less common forms of invasive Candidiasis (2007) J Antimicrob Chemother, 60 (2), pp. 363-369Sandven, P., Qvist, H., Skovlund, E., Giercksky, K.E., Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations (2002) Crit Care Med, 30 (3), pp. 541-547. , NO RGAS Group and the Norwegian Yeast Study GroupCalandra, T., Bille, J., Schneider, R., Mosimann, F., Francioli, P., Clinical significance of Candida isolated from peritoneum in surgical patients (1989) Lancet, 2 (8677), pp. 1437-1440Montravers, P., Dupont, H., Gauzit, R., Candida as a risk factor for mortality in peritonitis (2006) Crit Care Med, 34 (3), pp. 646-652Solomkin, J.S., Mazuski, J.E., Bradley, J.S., Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America (2010) Clin Infect Dis, 50 (2), pp. 133-164Stijn, I., Blota, B., Koenraad, H., Vandewoudea, B., Jan, J., Candida peritonitis (2007) Curr Opinion Crit Care, 13, pp. 195-199Azoulay, E., Cohen, Y., Zahar, J.R., Practices in nonneutropenic ICU patients with Candida-positive airway specimens (2004) Intensive Care Med, 30 (7), pp. 1384-1389Nunley, D.R., Gal, A.A., Vega, J.D., Perlino, C., Smith, P., Lawrence, E.C., Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation (2002) Chest, 122, pp. 1185-1191El-Ebiary, M., Torres, A., Fabregas, N., Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients An immediate postmortem histologic study (1997) Am J Respir Crit Care Med, 156, p. 583Alvarez-Lerma, F., Palomar, M., Leon, C., Olaechea, P., Cerda, E., Bermejo, B., Grupo de Estudio de Infecion Fungica Fungal colonization and/or infection in intensive care units. Multicenter study of 1,562 patients (2003) Med Clin (Barc), 121 (5), pp. 161-166Hiller, E., Zavrel, M., Hauser, N., Adaptation, adhesion and invasion during interaction of Candida albicans with the host-focus on the function of cell wall proteins (2011) Int J Med Microbiol, 301 (5), pp. 384-389Kontoyiannis, D.P., Reddy, B.T., Torres, H.A., Pulmonary Candidiasis in patients with cancer: an autopsy study (2002) Clin Infect Dis, 34, pp. 400-403Franquet, T., Muller, N.L., Lee, K.S., Oikonomou, A., Flint, J.D., Pulmonary Candidiasis after hematopoietic stem cell transplantation: thin-section CT findings (2005) Radiology, 236, pp. 332-337Oner-Eyuboglu, F., Karacan, O., Akcay, S., Arslan, H., Demirhan, B., Haberal, M., Invasive Pulmonary fungal infections in solid organ transplant recipients: a four-year review (2003) Transplant Proc, 35 (7), pp. 2689-2691Yamada, H., Kotaki, H., Takahashi, T., Recommendations for the treatment of fungal pneumonias (2003) Expert Opin Pharmacother, 4 (8), pp. 1241-1258Cole, G.T., Halawa, A.A., Anaisse, E.J., The role of the gastrointestinal tract in hematogenous Candidiasis: from the laboratory to the bedside (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. 73-88Alexander, J.W., Boyce, S.T., Babcock, G.F., The process of microbial translocation (1990) Annals of Surgery, 212, pp. 496-510Pfaller, M.A., Nosocomial Candidiasis: emerging species, reservoirs and modes of transmission (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. S89-S94Lunel, F.M.V., Meis, J.F.G.M., Voss, A., Nosocomial fungal infections: candidemia (1999) Diagn Microbiol Infect Dis, 34, pp. 213-220Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P., Hospital acquired candidemia The attributable mortality and excess length of stay (1988) Arch Int Med, 148, pp. 2642-2645Colombo, A.L., Perfect, J., DiNubile, M., Global distribution and outcomes for Candida species causing invasive Candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive Candidiasis (2003) Eur J Clin Microbiol Infect Dis, 22, pp. 470-474Ben-Ami, R., Garcia-Effron, G., Lewis, R.E., Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance (2011) J Infect Dis, 204 (4), pp. 626-635Pasqualotto, A.C., Zimerman, R.A., Alves, S.H., Aquino, V.R., Branco, D., Wiltgen, D., do Amaral, A., Sukiennik, T.C., Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil (2008) Infect Control Hosp Epidemiol, 29 (9), pp. 898-899Debusk, C.H., Daoud, R., Thirumoorthi, M.C., Wilson, F.M., Khatib, R., Candidemia: current epidemiologic characteristics and a longterm follow-up of the survivors (1994) Scand J Infect Dis, 26, pp. 697-703Kriengkauykiat, J., Ito, J.I., Dadwal, S.S., Epidemiology and treatment approaches in management of invasive fungal infections (2011) Clin Epidemiol, 3, pp. 175-191Bodey, G.P., Luna, M., Skin lesions associated with disseminated Candidiasis (1974) JAMA, 229, pp. 1466-1468Rodriguez-Adrian, L.J., King, R.T., Tamayo-Derat, L.G., Miller, J.W., Garcia, C.A., Rex, J.H., Retinal lesions as clues to disseminated bacterial and candidal infections: Frequency, natural history, and etiology (2003) Medicine (Baltimore), 82, pp. 187-202Oude Lashof, A.M., Rothova, A., Sobel, J.D., Ocular manifestations of candidemia (2011) Clin Infect Dis, 53 (3), pp. 262-268Krishna, R., Amuh, D., Lowder, C.Y., Gordon, S.M., Adal, K.A., Hall, G., Should all patients with candidemia have an ophthalmic examination to rule out ocular Candidiasis? (2000) Eye, 14, pp. 30-34Filler, S.G., Kullberg, B.J., Deep-seated candidal infections (2003) Medical Mycology, pp. 341-348. , Churchill Livingstone, Filadélfia, E. Anaissie, M.R. McGinnis, M.A. Pfaller (Eds.)Donnino, M.W., Goyal, N., Terlecki, T.M., Inadequate blood volume collected for culture: a survey of health care professionals (2007) Mayo Clin Proc, 82 (9), pp. 1069-1072Horvath, L.L., George, B.J., Hospenthal, D.R., Detection of fifteen species of Candida in an automated blood cultSanglard, D., Odds, F.C., Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences (2002) Lancet Infect Dis, 2, pp. 73-85Sullivan, D., Coleman, D., Candida dubliniensis: characteristics and identification (1998) J Clin Microbiol, 36, pp. 329-334Mariano, P.L., Milan, E.P., da Matta, D.A., Colombo, A.L., Candida dubliniensis identification in Brazilian yeast stock collection (2003) Mem Inst Oswaldo Cruz, 98 (4), pp. 533-538Krcmery, V., Barnes, A.J., Non-albicans Candida spp. causing fungemia: pathogenicity and antifungal resistance (2002) J Hosp Infect, 50, pp. 243-260Godoy, P., Tiraboschi, I.N., Severo, L.C., Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals (2003) Mem Instit Oswaldo Cruz, 98, pp. 401-405Pfaller, M.A., Nosocomial Candidiasis: emerging species, reservoirs and modes of transmission (1996) Clin Infect Dis, 22 (SUPPL. 2), pp. S89-S94Colombo, A.L., Guimarães, T., Silva, L.R., Prospective observational study of candidemia in São Paulo Brazil: incidence rate, epidemiology, and predictors of mortality (2007) Infect Control Hosp Epidemiol, 28 (5), pp. 570-576Costa, S.F., Marinho, I., Araújo, E.A., Manrique, A.E., Medeiros, E.A.S., Levin, A.S., Nosocomial fungaemia: a 2-year prospective study (2000) J Hosp Infect, 45, pp. 69-72Levin, A.S., Costa, S.F., Mussi, N.S., Candida parapsilosis fungemia associated with implantable and semiimplantable central venous catheters and the hands of health care workers (1998) Diagn Microbiol Infect Dis, 30, pp. 243-249Pfaller, M.A., Messer, S.A., Moet, G.J., Jones, R.N., Castanheira, M., Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENT RY Antimicrobial Surveillance Program (2008-2009) (2011) Int J Antimicrob Agents, 38 (1), pp. 65-69Pfaller, M.A., Diekema, D.J., Ostrosky-Zeichner, L., Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints (2008) J Clin Microbiol, 46 (8), pp. 2620-2629Mora-Duarte, J., Betts, R., Rotstein, C., Comparison of caspofungin and amphotericin B for invasive Candidiasis (2002) N Engl J Med, 347 (25), pp. 2020-2029Kuse, E.R., Chetchotisakd, P., da Cunha, C.A., Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial (2007) Lancet, 369 (9572), pp. 1519-1527Reboli, A.C., Rotstein, C., Pappas, P.G., Anidulafungin versus fluconazole for invasive Candidiasis (2007) N Engl J Med, 356 (24), pp. 2472-2482Kofteridis, D.P., Lewis, R.E., Kontoyiannis, D.P., Caspofungin-nonsusceptible Candida isolates in cancer patients (2010) J Antimicrob Chemother, 65 (2), pp. 293-295Colombo, A.L., Ngai, A.L., Bourque, M., Caspofungin use in patients with invasive Candidiasis caused by common non-albicans Candida species: review of the caspofungin database (2010) Antimicrob Agents Chemother, 54 (5), pp. 1864-1871Kale-Pradhan, P.B., Morgan, G., Wilhelm, S.M., Johnson, L.B., Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis Infections: a meta-analysis (2010) Pharmacotherapy, 30 (12), pp. 1207-1213Melo, A.S., Bizerra, F.C., Freymüller, E., Arthington-Skaggs, B.A., Colombo, A.L., Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex (2011) Med Mycol, 49 (3), pp. 253-262Wingard, J.R., Importance of Candida species other than C. albicans as pathogens in oncology patients (1995) Clin Infect Dis, 20, pp. 115-125Colombo, A.L., Nucci, M., Salomão, R., High rate of nonalbicans candidemia in Brazilian tertiary care hospitals (1999) Diagn Microbiol Infect Dis, 34, pp. 281-286Goldani, L.Z., Mario, P.S., Candida tropicalis fungemia in a tertiary care hospital (2003) J Infect, 46, pp. 150-160Alp, S., Sancak, B., Hascelik, G., Arikan, S., Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing
